10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 268 filers reported holding 10X GENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,647 | +124.7% | 64,162 | +204.2% | 0.03% | +233.3% |
| Q2 2023 | $1,178 | +24.5% | 21,092 | +24.4% | 0.01% | -18.2% |
| Q1 2023 | $946 | -9.1% | 16,957 | -40.6% | 0.01% | -15.4% |
| Q4 2022 | $1,041 | -99.9% | 28,557 | -9.3% | 0.01% | +18.2% |
| Q3 2022 | $897,000 | -60.6% | 31,500 | -37.3% | 0.01% | -54.2% |
| Q2 2022 | $2,274,000 | +832.0% | 50,248 | +1469.8% | 0.02% | +1100.0% |
| Q1 2022 | $244,000 | -93.6% | 3,201 | -87.7% | 0.00% | -88.9% |
| Q3 2021 | $3,802,000 | -33.4% | 26,116 | -10.4% | 0.02% | -33.3% |
| Q2 2021 | $5,705,000 | +488.1% | 29,135 | +443.8% | 0.03% | +440.0% |
| Q1 2021 | $970,000 | -76.6% | 5,358 | -81.7% | 0.01% | -77.3% |
| Q4 2020 | $4,139,000 | +1889.9% | 29,231 | +1650.4% | 0.02% | +2100.0% |
| Q3 2020 | $208,000 | +48.6% | 1,670 | +6.4% | 0.00% | 0.0% |
| Q2 2020 | $140,000 | -31.0% | 1,569 | -61.1% | 0.00% | -50.0% |
| Q3 2019 | $203,000 | – | 4,029 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $174,178,000 | 96.89% |
| Foresite Capital Management II, LLC | 2,253,528 | $407,889,000 | 93.76% |
| Foresite Capital Management I, LLC | 1,000,000 | $181,000,000 | 91.29% |
| 12 West Capital Management LP | 1,922,000 | $347,882,000 | 16.58% |
| FINANCIAL CONSULATE, INC | 158,758 | $28,735,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 2,123,356 | $384,327,000 | 9.48% |
| Andar Capital Management HK Ltd | 48,000 | $8,688,000 | 9.16% |
| JS Capital Management LLC | 517,256 | $93,623,000 | 4.84% |
| Ground Swell Capital, LLC | 3,713 | $672,000 | 2.17% |
| Renaissance Capital LLC | 79,518 | $14,393,000 | 2.13% |